Search Results - "Lehmann, Frédéric François"

SMART101 Donor T-Lymphoid Progenitors to Accelerate Immune Reconstitution Post-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide: SI101-02 First-in-Human Phase I/II by Devillier, Raynier, Peffault De Latour, Regis, Chevallier, Patrice, Huynh, Anne, Chiusolo, Patrizia, Bauquet, Aurelie, Simons, Laura, Heimendinger, Pierre, Negre, Olivier, Soheili, Shabi, Paillet, Juliette, Andre, Isabelle, Oster, Sebastien, Cavazzana, Marina, Lehmann, Frédéric François, Ciceri, Fabio

“…Background and Significance Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment option for many patients with…”
Get full text

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma by Nikiforow, Sarah, Werner, Lillian, Murad, Joana, Jacobs, Matthew, Johnston, Lauren, Patches, Sarah, White, Randie, Daley, Heather, Negre, Helene, Reder, Jake, Sentman, Charles, Wade, Terri, Schmucker, Adam, Lehmann, Frédéric François, Snykers, Sarah, Allen, Rachel, Dipietro, Heidi, Cummings, Kristen, Galinsky, Ilene, Munshi, Nikhil C., Schlossman, Robert L., Stone, Richard M., Neuberg, Donna S., Soiffer, Robert J., Dranoff, Glenn, Ritz, Jerome, Baumeister, Susanne H.C.

“…Introduction: Conventional CAR-T cells express a single chain antibody variable fragment that restricts recognition to one tumor antigen and a limited set of…”
Get full text